The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

[1]  K. Tew,et al.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Dekan,et al.  MRP and MDR1 gene expression in primary breast carcinomas. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Friedlander,et al.  MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. , 1996, Cancer letters.

[4]  Y. Maehara,et al.  Multidrug resistance‐associated protein expression in clinical gastric carcinoma , 1996, Cancer.

[5]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[6]  P. Houghton,et al.  P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Burger,et al.  Multidrug resistance-associated protein (MRP) in haematological malignancies. , 1996, Leukemia & lymphoma.

[8]  I. Andrulis,et al.  Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  S. Aaronson,et al.  Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. , 1995, Cancer research.

[10]  P. Sonneveld,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Y. Oshika,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. , 1995, British Journal of Cancer.

[12]  G. Giaccone,et al.  Prognostic relevance of P-glycoprotein expression in breast cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  D. Hipfner,et al.  Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. , 1994, Cancer research.

[14]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[15]  M. Haber,et al.  Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. , 1994, Cancer research.

[16]  P. Sonneveld,et al.  High expression of the multidrug resistance‐associated protein (MRP) in chronic and prolymphocytic leukaemia , 1994, British journal of haematology.

[17]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Meijer,et al.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. , 1994, Cancer research.

[19]  C. Willman,et al.  Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications , 1994, The Lancet.

[20]  P. Sonneveld,et al.  Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. , 1994, Leukemia.

[21]  P. Sonneveld,et al.  Clinical relevance of P-glycoprotein expression in haematological malignancies. , 1994, Leukemia research.

[22]  S. Aaronson,et al.  Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. , 1994, Cancer research.

[23]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[24]  M. Center,et al.  The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. , 1993, Cancer research.

[25]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[26]  J. Foekens,et al.  Cell biological factors associated with the response of breast cancer to systemic treatment. , 1993, Cancer treatment reviews.

[27]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[28]  W. McGuire,et al.  Prognostic factors and treatment decisions in axillary-node-negative breast cancer. , 1992, The New England journal of medicine.

[29]  J. Kuszak,et al.  Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. , 1991, Cancer research.

[30]  J. Foekens,et al.  Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. , 1989, Cancer research.

[31]  I. Pastan,et al.  MDR1 gene expression in lung cancer. , 1989, Journal of the National Cancer Institute.

[32]  W. McGuire,et al.  Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Laberge.  [Cancer of the breast]. , 1961, Laval medical.

[34]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[35]  K. Cowan,et al.  Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. , 1995, Blood.

[36]  V. Ling,et al.  The MDR superfamily of genes and its biological implications. , 1994, Important advances in oncology.

[37]  M. Barrand,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. , 1994, European journal of cancer.

[38]  L. Doyle.  Mechanisms of drug resistance in human lung cancer cells. , 1993, Seminars in oncology.

[39]  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute. , 1980, European Journal of Cancer.